{
  "id": "resp_0a429658c5614b8200693c9461c7a48193860e2a74a73e267f",
  "object": "response",
  "created_at": 1765577825,
  "status": "completed",
  "background": false,
  "billing": {
    "payer": "developer"
  },
  "error": null,
  "incomplete_details": null,
  "instructions": null,
  "max_output_tokens": null,
  "max_tool_calls": null,
  "model": "gpt-5.2-2025-12-11",
  "output": [
    {
      "id": "rs_0a429658c5614b8200693c9462dbdc81939a3892597d0d01cd",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0a429658c5614b8200693c94678fa08193b438078148fced4f",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "DDB1-CUL4-RBX1 drug candidate"
      }
    },
    {
      "id": "rs_0a429658c5614b8200693c946a51348193a52fd07325ad5a07",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0a429658c5614b8200693c949155188193beec8795a7187335",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "HQ461 molecular glue cyclin K degradation DDB1-CUL4-RBX1 development stage"
      }
    },
    {
      "id": "rs_0a429658c5614b8200693c9494b6a481938e55598548d58a0f",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0a429658c5614b8200693c94a067748193b1bb9266f3515d37",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "\"DDB1-CUL4-RBX1\" inhibitor drug"
      }
    },
    {
      "id": "rs_0a429658c5614b8200693c94a3d5588193abfc8508893ae416",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "msg_0a429658c5614b8200693c94b2e94881939984bdfb399978fd",
      "type": "message",
      "status": "completed",
      "content": [
        {
          "type": "output_text",
          "annotations": [],
          "logprobs": [],
          "text": "{\n  \"validated\": false,\n  \"assets\": [],\n  \"rejected_reason\": \"Candidate identifier \\\"DDB1-CUL4-RBX1\\\" refers to a CUL4-RBX1-DDB1 E3 ubiquitin ligase protein complex (mechanism/target component), not a therapeutic drug asset; therefore sponsor/indication/development stage/geography cannot be assigned. Evidence: https://pubmed.ncbi.nlm.nih.gov/32804079/ ; https://pubmed.ncbi.nlm.nih.gov/25108355/\"\n}"
        }
      ],
      "role": "assistant"
    }
  ],
  "parallel_tool_calls": true,
  "previous_response_id": null,
  "prompt_cache_key": null,
  "prompt_cache_retention": null,
  "reasoning": {
    "effort": "xhigh",
    "summary": null
  },
  "safety_identifier": null,
  "service_tier": "default",
  "store": true,
  "temperature": 1.0,
  "text": {
    "format": {
      "type": "text"
    },
    "verbosity": "medium"
  },
  "tool_choice": "auto",
  "tools": [
    {
      "type": "web_search",
      "filters": null,
      "search_context_size": "medium",
      "user_location": {
        "type": "approximate",
        "city": null,
        "country": "US",
        "region": null,
        "timezone": null
      }
    }
  ],
  "top_logprobs": 0,
  "top_p": 0.98,
  "truncation": "disabled",
  "usage": {
    "input_tokens": 20268,
    "input_tokens_details": {
      "cached_tokens": 4736
    },
    "output_tokens": 5380,
    "output_tokens_details": {
      "reasoning_tokens": 5261
    },
    "total_tokens": 25648
  },
  "user": null,
  "metadata": {}
}